Laws: Cases and Codes : U.S. Code : Title 42 : Section 7671d


   
U.S. Code as of: 01/19/04
Section 7671d. Phase-out of production and consumption of class II substances

    (a) Restriction of use of class II substances
      Effective January 1, 2015, it shall be unlawful for any person to
    introduce into interstate commerce or use any class II substance
    unless such substance - 
        (1) has been used, recovered, and recycled;
        (2) is used and entirely consumed (except for trace quantities)
      in the production of other chemicals; or
        (3) is used as a refrigerant in appliances manufactured prior
      to January 1, 2020.

    As used in this subsection, the term "refrigerant" means any class
    II substance used for heat transfer in a refrigerating system.
    (b) Production phase-out
      (1) Effective January 1, 2015, it shall be unlawful for any
    person to produce any class II substance in an annual quantity
    greater than the quantity of such substance produced by such person
    during the baseline year.
      (2) Effective January 1, 2030, it shall be unlawful for any
    person to produce any class II substance.
    (c) Regulations regarding production and consumption of class II
      substances
      By December 31, 1999, the Administrator shall promulgate
    regulations phasing out the production, and restricting the use, of
    class II substances in accordance with this section, subject to any
    acceleration of the phase-out of production under section 7671e of
    this title. The Administrator shall also promulgate regulations to
    insure that the consumption of class II substances in the United
    States is phased out and terminated in accordance with the same
    schedule (subject to the same exceptions and other provisions) as
    is applicable to the phase-out and termination of production of
    class II substances under this subchapter.
    (d) Exceptions
      (1) Medical devices
        (A) In general
          Notwithstanding the termination of production required under
        subsection (b)(2) of this section and the restriction on use
        referred to in subsection (a) of this section, the
        Administrator, after notice and opportunity for public comment,
        shall, to the extent such action is consistent with the
        Montreal Protocol, authorize the production and use of limited
        quantities of class II substances solely for purposes of use in
        medical devices if such authorization is determined by the
        Commissioner, in consultation with the Administrator, to be
        necessary for use in medical devices.
        (B) Cap on exception
          Under no circumstances may the authority set forth in
        subparagraph (A) be applied to authorize any person to produce
        a class II substance in annual quantities greater than 10
        percent of that produced by such person during the baseline
        year.
      (2) Developing countries
        (A) In general
          Notwithstanding the provisions of subsection (a) or (b) of
        this section, the Administrator, after notice and opportunity
        for public comment, may authorize the production of limited
        quantities of a class II substance in excess of the quantities
        otherwise permitted under such provisions solely for export to
        and use in developing countries that are Parties to the
        Montreal Protocol, as determined by the Administrator. Any
        production authorized under this subsection shall be solely for
        purposes of satisfying the basic domestic needs of such
        countries.
        (B) Cap on exception
          (i) Under no circumstances may the authority set forth in
        subparagraph (A) be applied to authorize any person to produce
        a class II substance in any year following the effective date
        of subsection (b)(1) of this section and before the year 2030
        in annual quantities greater than 110 percent of the quantity
        of such substance produced by such person during the baseline
        year.
          (ii) Under no circumstances may the authority set forth in
        subparagraph (A) be applied to authorize any person to produce
        a class II substance in the year 2030, or any year thereafter,
        in an annual quantity greater than 15 percent of the quantity
        of such substance produced by such person during the baseline
        year.
          (iii) Each exception authorized under this paragraph shall
        terminate no later than January 1, 2040.



Previous [Notes] Next

Related Resources

Health Law Guide

Health Articles and Documents

Health Discussion

Ads by FindLaw